Clinical Trial Update: Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study comparing two manufacturing methods of daprodustat formulations for bioequivalence and dissolution in healthy participants; results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Daprodustat (daprodustat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED | Results posted: 2023-01-26